Dr Tony Lockett is a Senior Lecturer in the Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, School of Cancer & Pharmaceutical Sciences.

Dr Lockett initially trained in medicine at Newcastle University and in infectious diseases and tropical medicine at Public Health England and the London School of Hygiene & Tropical Medicine. He joined the pharmaceutical industry in 1990, where he worked in antimicrobial development for Park-Davis (now Pfizer). He left his post to complete a PhD in economics at St Andrew's University and an MBA from Henley Management College. Following his PhD, he became head of translational medicine in Covance, before joining an NIH spinout in vaccines and nanotechnology. He returned to the UK in 2009 to take the post of Chief Medical Officer at HVivo - a respiratory specialist CRO in London, and joined King's as a Lecturer shortly after. Dr Lockett has published extensively on the role of data and health economics. He has consulted with companies in and outside of King's on market access strategies in diagnostic technology and neurology drugs and devices.

In addition to teaching at King's, Dr Lockett is medical director of a small company developing different technologies (drugs and devices) in neurodegeneration and aging diseases, and medical director to a patient charity on MND. He has over 15 years of small company management experience in medical innovation. He is also a chair of an HRA ethics committee in the UK with a focus on advanced medical product research.